Le Lézard
Classified in: Health, Science and technology
Subjects: TDS, FVT

Fifth-Annual HITLAB Innovators Summit Announced, Assembling Leaders Across Digital Health Ecosystem


NEW YORK, Nov. 19, 2018 /PRNewswire/ -- Inspiring the next five years of healthcare changemakers is the goal of the 2018 HITLAB Innovators Summit: New York. The two-day event is sponsored by Nestlé Skin Health, Columbia Business School, and Playing Forward and begins Tuesday, November 28. It brings together leaders in life sciences, technology, public health, medicine, investment, and design to discuss pressing global health issues and digital solutions.

This Summit, now in its fifth year, is centered around disruptors?those driving change across the digital health ecosystem and redefining what is possible in healthcare delivery. Topics range from establishing a culture of innovation in life science companies to examining the current state of startup accelerators.

"Attendees can expect to hear from those pushing the envelope of what is possible across the entire digital health ecosystem," said Stan Kachnowski, HITLAB Chair. "From venture capital to academic medical centers, this Summit goes deeper into the most diffusive technologies and diverse groups driving change."

The event will feature an engagement session led by Steven Krein, StartUp Health CEO, along with panels and speaker presentations from leaders representing Google Launchpad, Dreamit Ventures, NewYork-Presbyterian, HealthTree, Merck Global Health Fund, and more. Playing Forward will occupy an exhibitor area showing the latest mixed-reality technology.

"Playing Forward is thrilled to sponsor the HITLAB Innovators Summit: New York," said Victor Talbot, Playing Forward Co-Founder. "We are deeply invested in the potential of digital health to transform the continuum of care, and our flagship GaitWay XR initiative showcases the power of cross-domain collaboration between neuroscientists, researchers, game designers, animators, and technologists to create an immersive experience for both in-clinic diagnosis and at-home therapeutics."

Details for the 2019 HITLAB World Cup?an annual global contest open to digital health innovators and entrepreneurs?will be announced. Its theme: Women's Health Tech.

Tickets for the 2018 HITLAB Innovators Summit: New York are now available for purchase and seating is limited. Learn more about the event, agenda, and sponsors here.

About HITLAB

HITLAB is an impact-first innovation and teaching organization based in New York City dedicated to improving healthcare delivery worldwide.

Our team of public health professionals, statisticians, entrepreneurs, clinicians, engineers, economists, strategists, designers, and anthropologists is determined to address healthcare needs across the globe. We work with a wide variety of stakeholders in both the public and private sectors to design and disseminate studies, programs, and products that improve healthcare access and delivery.

Every year, the organization hosts the HITLAB Innovators Summit, which brings together leaders in public health, medicine, technology, and design to discuss health issues and solutions in a two-day live event. The Summit offers a series of carefully curated talks, panels, and collaboration opportunities to engage the most creative minds in health and technology.

For more information, please visit www.hitlab.org or follow the company on Twitter @HITLabNYC.

Contact:
Ken Gardner
HITLAB
[email protected]

 

SOURCE HITLAB


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: